|
PARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.861800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.616600E-01 |
| Normal-vs-Stage2 |
7.348400E-01 |
| Normal-vs-Stage3 |
3.276200E-01 |
| Normal-vs-Stage4 |
5.634300E-02 |
| Stage1-vs-Stage2 |
6.545700E-02 |
| Stage1-vs-Stage3 |
9.088600E-01 |
| Stage1-vs-Stage4 |
1.632040E-01 |
| Stage2-vs-Stage3 |
1.158560E-01 |
| Stage2-vs-Stage4 |
1.285960E-02 |
| Stage3-vs-Stage4 |
1.778770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.377000E-01 |
| Normal-vs-AfricanAmerican |
6.999400E-01 |
| Normal-vs-Asian |
1.269010E-01 |
| Caucasian-vs-AfricanAmerican |
7.750800E-01 |
| Caucasian-vs-Asian |
2.659000E-01 |
| AfricanAmerican-vs-Asian |
4.307000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.691800E-01 |
| Normal-vs-Female |
2.764000E-01 |
| Male-vs-Female |
8.241600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.385380E-01 |
| Normal-vs-Age(41-60Yrs) |
6.114600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.127400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.370180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.580000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.061000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.627000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.965800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.094040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.816400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.984400E-01 |
| Classical-VS-Follicular |
7.410000E-01 |
| Classical-VS-Other |
9.983400E-01 |
| Classical-VS-Normal |
4.588000E-01 |
| Tall-VS-Follicular |
5.807800E-01 |
| Tall-VS-Other |
8.114400E-01 |
| Tall-VS-Normal |
2.165400E-01 |
| Follicular-VS-Other |
9.492600E-01 |
| Follicular-VS-Normal |
3.960800E-01 |
| Other-VS-Normal |
7.884600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.221600E-01 |
| Normal-vs-N1 |
2.437000E-03 |
| N0-vs-N1 |
1.028330E-04 |
|
|
